Court Orders Johnson & Johnson To Compensate Auris Health Shareholders $1B

Johnson & Johnson (NYSE:JNJ) has reportedly been ordered to pay $1 billion in damages to Auris Health shareholders for breaching a 2019 acquisition agreement, according to a ruling by Delaware’s Court of Chancery.

Vice Chancellor Lori Will’s decision came after a two-week trial, finding that Johnson & Johnson failed to support Auris’ iPlatform technology, which was critical for earning additional payments to Auris’ investors.

Also Read: Despite Medicare Negotiations, Americans May Still Have To Pay More For Prescription Drugs.

The dispute centers around ...